author-photo

V Abitbol

University of Paris

2

Papers

5

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Outcomes after double switching from originator Infliximab to biosimilar CT‐P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12‐month prospective cohort study

2021 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
Prognosis of lymphoma in patients with known Inflammatory Bowel Disease: a French multicentre cohort study.

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (2)